ESHELMAN FREDRIC N
Transactions
50
Companies
10
Filings
13
CIK
0001033409
Recent Transactions
- Award
- Award
- Award
- Award
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Disposition to Issuer
- Award
- Award
- Award
- Purchase
- Award
- Award
- Award
- Purchase
- Purchase
- Purchase
Companies
10Aravive, Inc.
Director
- $BHC
Bausch Health Companies Inc.
Director
Furiex Pharmaceuticals, Inc.
Director
G1 Therapeutics, Inc.
Director, 10% Owner
- $HYPD
HYPERION DEFI, INC.
Director, 10% Owner
- $JSPR
Jasper Therapeutics, Inc.
Director
- $LQDA
Liquidia Corp
10% Owner
Liquidia Technologies Inc
10% Owner
MEDICINES CO /DE
Director
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Director, CEO
Recent Filings
13- 4
ESHELMAN FREDRIC N
Oct 26, 2022
- 4
ESHELMAN FREDRIC N
Sep 26, 2022
- 4
ESHELMAN FREDRIC N
Apr 4, 2022
- 4
ESHELMAN FREDRIC N
Mar 31, 2022
- 4
ESHELMAN FREDRIC N
Jan 5, 2022
- 4
ESHELMAN FREDRIC N
Nov 22, 2021
- 4
ESHELMAN FREDRIC N
Sep 13, 2021
- 4
ESHELMAN FREDRIC N
Feb 17, 2021
- 4
Eshelman Ventures, LLC
Jan 27, 2021
- 4
Eshelman Ventures, LLC
Jan 26, 2021
- 4
Eshelman Ventures, LLC
Jan 22, 2021
- 4
Eshelman Ventures, LLC
Jan 21, 2021
- 4
Eshelman Ventures, LLC
Jan 19, 2021
Address
929 NORTH FRONT STREET
WILMINGTON, NC, 28401